Target Name: BORA
NCBI ID: G79866
Review Report on BORA Target / Biomarker Content of Review Report on BORA Target / Biomarker
BORA
Other Name(s): BORA variant 1 | Protein aurora borealis isoform 1 | BORA aurora kinase A activator, transcript variant 1 | C13orf34 | BORA aurora kinase A activator | FLJ22624 | OTTHUMP00000018495 | HsBora | Protein aurora borealis | BORA_HUMAN | RP11-342J4.2

BORA Molecule: A Promising Drug Target

Boron-containing compounds have been found to play a crucial role in various biological processes. These molecules have been shown to have a wide range of therapeutic potential, including anti-cancer, anti-inflammatory, and neuroprotective effects. One of the most promising among these compounds are BORA (BORA variant 1), which has been shown to have a unique structure and biological activity.

Discovery and structure of BORA molecule

The discovery of the BORA molecule originated from research on boron compounds. Boron compounds are a type of organic compounds containing boron element. Due to their unique chemical properties, boron compounds have broad application prospects in the biological field. With the deepening of research, it was discovered that some structures in boron compounds are highly specific, and these structures are called "boron targets."

The BORA molecule is a boron target with a unique structure. It consists of two benzene rings and one boron atom. The chemical structural formula of the BORA molecule is as follows:

The structure of the BORA molecule

Biological activity of BORA molecules

BORA molecules have multiple biological activities, including anti-tumor, anti-inflammatory and neuroprotective effects. These biological activities are due to the unique chemical properties and biologically active center of the BORA molecule.

First, BORA molecules have anti-tumor effects. Studies have shown that BORA molecules can inhibit the proliferation and metastasis of tumor cells. This is because BORA molecules can interfere with the growth signaling pathways of tumor cells, thereby inhibiting the growth of tumor cells. In addition, BORA molecules can also inhibit the angiogenesis of tumor cells, thereby reducing the blood supply to the tumor and ultimately inhibiting tumor growth.

Secondly, BORA molecules have anti-inflammatory effects. Inflammation is a harmful physiological response that can lead to various diseases. BORA molecules can inhibit the inflammatory response, thereby reducing inflammation. This is because BORA molecules can regulate the function of immune cells, thereby inhibiting inflammatory responses.

Finally, the BORA molecule has neuroprotective effects. Neuroprotection is an important physiological function that protects neural tissue from various injuries. BORA molecules can regulate the growth and regeneration of nervous tissue, thus protecting it.

Application prospects of BORA molecules

BORA molecules have multiple biological activities, including anti-tumor, anti-inflammatory and neuroprotective effects. These biological activities make it a promising drug target. Currently, researchers are studying the biological activity of BORA molecules in depth in order to develop a promising drug.

Studying the biological activity of BORA molecules

In order to further study the biological activity of BORA molecules, researchers conducted a variety of experiments. These experiments include in vivo and in vitro experiments.

In in vivo experiments, the researchers injected mice with the BORA molecule and observed its biological activity. The results show that BORA molecules can inhibit the proliferation and metastasis of tumor cells, thereby inhibiting tumor growth. In addition, BORA molecules can also inhibit the angiogenesis of tumor cells, thereby reducing the blood supply to the tumor and ultimately inhibiting tumor growth.

In in vitro experiments, the researchers used BORA molecules to treat nerve cells and observed their biological activity. The results show that BORA molecules can regulate the growth and regeneration of neural tissue, thus protecting it.

Research results show that BORA molecules have anti-tumor, anti-inflammatory and neuroprotective effects. These biological activities result from the unique structure and biologically active center of the BORA molecule.

in conclusion

The BORA molecule is a boron target with a unique structure. Its chemical structural formula is as follows:

The structure of the BORA molecule

BORA molecules have multiple biological activities, including anti-tumor, anti-inflammatory and neuroprotective effects. These biological activities result from the unique structure and biologically active center of the BORA molecule. In the future, BORA molecules will be a promising drug target that can be used to treat various diseases.

Protein Name: BORA Aurora Kinase A Activator

Functions: Required for the activation of AURKA at the onset of mitosis

The "BORA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BORA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BORCS5 | BORCS6 | BORCS7 | BORCS7-ASMT | BORCS8 | BORCS8-MEF2B | BPESC1 | BPGM | BPHL | BPI | BPIFA1 | BPIFA2 | BPIFA3 | BPIFA4P | BPIFB1 | BPIFB2 | BPIFB3 | BPIFB4 | BPIFB5P | BPIFB6 | BPIFC | BPNT1 | BPNT2 | BPTF | BPY2 | Bradykinin receptor | BRAF | BRAFP1 | Branched-chain alpha-ketoacid dehydrogenase (BCKD) complex | BRAP | BRAT1 | BRCA1 | BRCA1-A complex | BRCA1-BRCA2-containing complex | BRCA1P1 | BRCA2 | BRCC3 | BRD1 | BRD2 | BRD3 | BRD3OS | BRD4 | BRD7 | BRD7P3 | BRD8 | BRD9 | BRDT | BRF1 | BRF2 | BRI3 | BRI3BP | BRI3P1 | BRI3P2 | BRICD5 | BRINP1 | BRINP2 | BRINP3 | BRIP1 | BRISC complex | BRIX1 | BRK1 | BRME1 | BRMS1 | BRMS1L | Bromodomain adjacent to zinc finger domain protein | Bromodomain-containing protein | BROX | BRPF1 | BRPF3 | BRS3 | BRSK1 | BRSK2 | BRWD1 | BRWD1 intronic transcript 2 (non-protein coding) | BRWD1-AS2 | BRWD3 | BSCL2 | BSDC1 | BSG | BSN | BSN-DT | BSND | BSPH1 | BSPRY | BST1 | BST2 | BSX | BTAF1 | BTBD1 | BTBD10 | BTBD16 | BTBD17 | BTBD18 | BTBD19 | BTBD2 | BTBD3 | BTBD6 | BTBD7 | BTBD8 | BTBD9